Sanofi Income from Continuous Operations 2010-2024 | SNY

Sanofi income from continuous operations for the twelve months ending September 30, 2024 was $4.961B, a 49.27% decline year-over-year.

  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
  • Sanofi annual income from continuous operations for 2022 was $8.939B, a 20.33% increase from 2021.
  • Sanofi annual income from continuous operations for 2021 was $7.429B, a 47.34% decline from 2020.

Sanofi Income from Continuous Operations 2010-2024 | SNY

  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
  • Sanofi annual income from continuous operations for 2022 was $8.939B, a 20.33% increase from 2021.
  • Sanofi annual income from continuous operations for 2021 was $7.429B, a 47.34% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Innoviva (INVA)$1.2B